IBDEI0VT ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15457,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,15457,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,15457,2)
 ;;=Hypocalcemia^60542
 ;;^UTILITY(U,$J,358.3,15458,0)
 ;;=276.7^^81^944^29
 ;;^UTILITY(U,$J,358.3,15458,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15458,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,15458,1,5,0)
 ;;=5^Hyperkalemia/Hyperpotassemia
 ;;^UTILITY(U,$J,358.3,15458,2)
 ;;=Hyperkalemia/Hyperpotassemia^60042
 ;;^UTILITY(U,$J,358.3,15459,0)
 ;;=276.8^^81^944^32
 ;;^UTILITY(U,$J,358.3,15459,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15459,1,4,0)
 ;;=4^276.8
 ;;^UTILITY(U,$J,358.3,15459,1,5,0)
 ;;=5^Hypokalemia/Hypopotassemia
 ;;^UTILITY(U,$J,358.3,15459,2)
 ;;=Hypokalemia/Hypopotassemia^60611
 ;;^UTILITY(U,$J,358.3,15460,0)
 ;;=275.2^^81^944^26
 ;;^UTILITY(U,$J,358.3,15460,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15460,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,15460,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,15460,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,15461,0)
 ;;=276.0^^81^944^30
 ;;^UTILITY(U,$J,358.3,15461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15461,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,15461,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,15461,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,15462,0)
 ;;=276.1^^81^944^33
 ;;^UTILITY(U,$J,358.3,15462,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15462,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,15462,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,15462,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,15463,0)
 ;;=275.3^^81^944^27
 ;;^UTILITY(U,$J,358.3,15463,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15463,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,15463,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,15463,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,15464,0)
 ;;=250.40^^81^944^16
 ;;^UTILITY(U,$J,358.3,15464,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15464,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,15464,1,5,0)
 ;;=5^DM type II with Nephropathy
 ;;^UTILITY(U,$J,358.3,15464,2)
 ;;=DM type II with Nephropathy^267837^583.81
 ;;^UTILITY(U,$J,358.3,15465,0)
 ;;=790.93^^81^944^1
 ;;^UTILITY(U,$J,358.3,15465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15465,1,4,0)
 ;;=4^790.93
 ;;^UTILITY(U,$J,358.3,15465,1,5,0)
 ;;=5^Abnormal PSA
 ;;^UTILITY(U,$J,358.3,15465,2)
 ;;=Abnormal PSA^295772
 ;;^UTILITY(U,$J,358.3,15466,0)
 ;;=627.3^^81^944^3
 ;;^UTILITY(U,$J,358.3,15466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15466,1,4,0)
 ;;=4^627.3
 ;;^UTILITY(U,$J,358.3,15466,1,5,0)
 ;;=5^Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,15466,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,15467,0)
 ;;=607.1^^81^944^6
 ;;^UTILITY(U,$J,358.3,15467,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15467,1,4,0)
 ;;=4^607.1
 ;;^UTILITY(U,$J,358.3,15467,1,5,0)
 ;;=5^Balanitis
 ;;^UTILITY(U,$J,358.3,15467,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,15468,0)
 ;;=596.0^^81^944^7
 ;;^UTILITY(U,$J,358.3,15468,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15468,1,4,0)
 ;;=4^596.0
 ;;^UTILITY(U,$J,358.3,15468,1,5,0)
 ;;=5^Bladder Neck Obstruction
 ;;^UTILITY(U,$J,358.3,15468,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,15469,0)
 ;;=595.0^^81^944^10
 ;;^UTILITY(U,$J,358.3,15469,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15469,1,4,0)
 ;;=4^595.0
 ;;^UTILITY(U,$J,358.3,15469,1,5,0)
 ;;=5^Cystitis, Acute
 ;;^UTILITY(U,$J,358.3,15469,2)
 ;;=^259104
 ;;^UTILITY(U,$J,358.3,15470,0)
 ;;=595.82^^81^944^11
 ;;^UTILITY(U,$J,358.3,15470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15470,1,4,0)
 ;;=4^595.82
 ;;^UTILITY(U,$J,358.3,15470,1,5,0)
 ;;=5^Cystitis, Radiation
 ;;
 ;;$END ROU IBDEI0VT
